SKF 106760
SKF 106760 is a potent platelet fibrin receptor (glycoprotein IIb/IIIa) antagonist with significant antiplatelet and antithrombotic activities. SKF 106760 inhibits platelet aggregation in dogs in vitro and prevents thrombus formation in stenotic carotid arteries. SKF 106760 has also shown elimination effects against aspirin-resistant thrombi that develop in the setting of high-grade stenosis[1].
Product Specifications
CAS Number
126053-71-2
UNSPSC
12352209
Target
Endogenous Metabolite
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/skf-106760.html
Smiles
N=C(N)NCCC[C@@H]1N(C([C@H](CSSC(C)([C@H](NC([C@@H](NC(CNC1=O)=O)CC(O)=O)=O)C(N)=O)C)NC(C)=O)=O)C
Molecular Formula
C23H39N9O8S2
Molecular Weight
633.74
References & Citations
[1]Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MUC1 / EMA / CD227 (Epithelial Marker) (rMUC1/960), CF405S conjugate, 0.1mg/mL
